Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To evaluate the long-term efficacy of secukinumab 75 and 150 mg (provided as pre-filled syringes) with respect to ACR20, ACR50 and ACR70 response over time up to Week 260 in subjects with active psoriatic arthritis and who complete the phase III study CAIN457F2306
Critère d'inclusion
- Psoriatic Arthritis